Home > Insider Trading > Filing (0001567619-19-015745)

Filing Details

Accession Number:: 0001567619-19-015745
Form Type:: 4/A
Zero Holdings:: No
Publication Time:: 2019-08-02 20:53:02
Reporting Period:: 2006-10-31

Accepted Time:: 2019-08-02 20:53:02
Original Submission Date:: 2018-04-04
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
826253	Aura Systems Inc	AUSI	Miscellaneous Electrical Machinery, Equipment & Supplies (3690)	954106894

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1354114	Warren Breslow	721 N. Rexford Drive Beverly Hills CA 90210		No	No	Yes	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2006-10-31	9,821	$0.00	49,106	No	4	P	Indirect	See Footnotes
Common Stock	Acquisiton	2007-11-09	62,794	$6.37	111,900	No	4	P	Indirect	See Footnotes
Common Stock	Acquisiton	2008-02-28	15,698	$0.00	127,598	No	4	P	Indirect	See Footnotes
Common Stock	Acquisiton	2008-05-01	7,857	$7.00	135,455	No	4	P	Indirect	See Footnotes
Common Stock	Acquisiton	2007-04-26	54,945	$2.73	54,945	No	4	P	Indirect	See Footnotes
Common Stock	Acquisiton	2008-04-11	13,736	$0.00	68,681	No	4	P	Indirect	See Footnotes
Common Stock	Acquisiton	2007-08-03	43,473	$4.60	43,473	No	4	P	Indirect	See Footnotes
Common Stock	Acquisiton	2007-09-05	7,403,705	$0.34	7,447,178	No	4	P	Indirect	See Footnotes
Common Stock	Acquisiton	2009-02-27	14,285	$0.00	7,461,463	No	4	P	Indirect	See Footnotes
Common Stock	Acquisiton	2011-02-07	6,620	$4.90	7,468,083	No	4	P	Indirect	See Footnotes
Common Stock	Acquisiton	2016-06-08	10,528	$7.00	7,478,611	No	4	P	Indirect	See Footnotes

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Indirect	See Footnotes
No	4	P	Indirect	See Footnotes
No	4	P	Indirect	See Footnotes
No	4	P	Indirect	See Footnotes
No	4	P	Indirect	See Footnotes
No	4	P	Indirect	See Footnotes
No	4	P	Indirect	See Footnotes
No	4	P	Indirect	See Footnotes
No	4	P	Indirect	See Footnotes
No	4	P	Indirect	See Footnotes
No	4	P	Indirect	See Footnotes

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Convertible Promissory Note	Acquisiton	2018-02-14	0	$0.00	2,142,857	$1.40
Common Stock	Common Stock Warrants (right to buy)	Acquisiton	2013-02-28	285,714	$0.00	285,714	$1.40
Common Stock	Common Stock Warrants (right to buy)	Acquisiton	2013-02-28	300,000	$0.00	14,286	$1.40
Common Stock	Common Stock Warrants (right to buy)	Acquisiton	2014-06-03	342,857	$0.00	42,857	$1.40
Common Stock	Common Stock Warrants (right to buy)	Acquisiton	2014-06-03	485,714	$0.00	142,857	$1.40
Common Stock	Common Stock Warrants (right to buy)	Acquisiton	2014-06-03	492,857	$0.00	7,143	$1.40
Common Stock	Common Stock Warrants (right to buy)	Acquisiton	2014-06-03	664,286	$0.00	171,429	$1.40
Common Stock	Common Stock Warrants (right to buy)	Acquisiton	2014-06-03	950,000	$0.00	285,714	$1.40
Common Stock	Common Stock Warrants (right to buy)	Acquisiton	2018-02-14	966,000	$0.00	16,000	$1.40

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0	2018-02-14	2023-02-14	No	4	A	Indirect
285,714	2013-02-28	2020-02-27	No	4	A	Direct
300,000	2013-02-28	2020-02-27	No	4	A	Direct
342,857	2014-06-03	2021-06-02	No	4	A	Direct
485,714	2014-06-03	2021-06-02	No	4	A	Direct
492,857	2014-06-03	2021-06-02	No	4	A	Direct
664,286	2014-06-03	2021-06-02	No	4	A	Direct
950,000	2014-06-03	2021-06-02	No	4	A	Direct
966,000	2018-02-14	2023-02-13	No	4	A	Direct

Footnotes

Issued by the Issuer for no consideration as "penalty shares" from related to prior issuances.
The Form 4 previously filed on April 4, 2018 to which this amendment relates inadvertently did not reflect the correct aggregate number of securities beneficially owned by Warren Breslow (the "Reporting Person") in Table I and did not reflect certain securities acquired by the Reporting Person. The footnotes listed below reflect the number of securities beneficially owned by the Reporting Person as of the respective dates referenced therein and the relevant record holders' names. All securities numbers reported herein reflect a 1 for 7 reverse stock split which became effective on 02/15/18.
135,455 shares of common stock, par value $0.0001 per share ("Common Stock"), are held of record (the "Texas Ridge Shares") by Texas Ridge Investment Co., A California Limited Partnership ("Texas Ridge"), of which the Reporting Person is a trustee of the general partner. By virtue of the Reporting Person's direct or indirect control of Texas Ridge, the Reporting Person may be deemed to beneficially own some or all of the Texas Ridge Shares but disclaims beneficial ownership of the Texas Ridge Shares except to the extent of the Reporting Person's pecuniary interest therein.
68,681 shares of Common Stock (the "Lancelot Shares") are held of record by Lancelot Investment Co., L.P. ("Lancelot"), of which the Reporting Person is the manager of the general partner thereof. By virtue of the Reporting Person's direct or indirect control of Lancelot, the Reporting Person may be deemed to beneficially own some or all of the Lancelot Shares but disclaims beneficial ownership of the Lancelot Shares except to the extent of the Reporting Person's pecuniary interest therein.
7,478,611 shares of Common Stock (the "Survivor's Trust Shares") are held of record by the Reporting Person as trustee of The Survivor's Trust Under the Warren L. Breslow Trust (the "Survivor's Trust"). By virtue of the Reporting Person's control of the Survivor's Trust, the Reporting Person may be deemed to beneficially own some or all of the Survivor's Trust Shares but disclaims beneficial ownership of the Survivor's Trust Shares except to the extent of the Reporting Person's pecuniary interest therein.
The Form 4 to which this amendment relates inadvertently omitted this transaction. As previously reported in the Issuer's public SEC filings, pursuant to a Debt Refinancing Agreement entered into as of January 24, 2017 between the Company and the trustee of the Survivor's Trust, the Survivor's Trust holds an Unsecured Convertible Promissory Note (the "Note") with an original principal amount of $3,000,000 pursuant to which the Survivor's Trust has the right to convert principal and interest amounts outstanding thereunder in whole or in part into shares of the Company's Common Stock at a conversion price of $1.40 per share. The Note provides that the Company is to pay accrued interest monthly in arrears, but to the extent the Company does not do so, the amount of accrued and unpaid interest could be converted into shares of Common Struck pursuant to the terms of the Note. The principal amount and any accrued interest outstanding under the Note are due and payable on February 14, 2023.
2,142,857 shares of Common Stock were issuable as of February 14, 2018 assuming the conversion of the $3,000,000 principal amount outstanding as of such date, but not including additional shares that would be issuable to the extent of any accrued and unpaid interest thereon, if any. As of the date hereof, the Survivor's Trust has not converted any principal or accrued interest under the Note into shares of Common Stock.
By virtue of the Reporting Person's control of the Survivor's Trust, the Reporting Person may be deemed to beneficially own some or all of the Conversion Shares but disclaims beneficial ownership of the Conversion Shares, except to the extent of the Reporting Person's pecuniary interest therein.
966,000 shares of Common Stock are issuable to the Reporting Person upon exercise of warrants each having an exercise price of $1.40 per share (the "Warrants"), and with expiration dates beginning February 27, 2020 and ending February 13, 2023.
The Form 4 to which this amendment relates inadvertently did not separately report in Table II the Reporting Person's individual warrants granted between 02/28/13 and 02/14/18.